Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients

• मुख्य लेखकों: Francesca Barei (लेखक), Martina Zussino (लेखक), Simona Tavecchio (लेखक), Luisa Angileri (लेखक), Arianna Rizzo (लेखक), Paolo Calzari (लेखक), Angelo V. Marzano (लेखक), Silvia Ferrucci (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: The main objective was to analyze patient-reported outcomes (PRO) trends over a four-year period in severe atopic dermatitis (AD) patients treated with dupilumab. Methods: data from 126 severe patients receiving dupilumab for at least 48 months were collected. The clinical scores assesse...